Belantamab mafodotin (belamaf) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for patients (pts) with transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM): A focus on treatment efficacy and management/resolution of ocular events in the Phase 1 dreamm-9 study


Por: Usmani, S, Mielnik, M, Alonso, AA, Abdallah, A, Garg, M, Janowski, W, Koh, Y, Min, CK, Ocio, E, Quach, H, Ramasamy, K, Oriol, A, Rodriguez-Otero, P, Sanchez, RG, Sandhu, I, Weisel, K, Brawley, C, Murillo, M, Carreño, F, Egger, J, Kaisermann, M and Hus, M

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:


Filiaciones:
Usmani, S:
 Mem Sloan Kettering Canc Ctr, New York, NY USA

Mielnik, M:
 Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland

Alonso, AA:
 Univ Cantabria, Hosp Univ Marques de Valdecilla IDIVAL, Santander, Spain

 Hosp Quiron Madrid, Madrid, Spain

Abdallah, A:
 Univ Kansas, Med Ctr, US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS USA

Garg, M:
 Leicester Royal Infirm, Leicester, England

Janowski, W:
 Calvary Mater Newcastle, Newcastle, Australia

Koh, Y:
 Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

Min, CK:
 Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Seoul, South Korea

Ocio, E:
 Univ Cantabria, Hosp Univ Marques de Valdecilla IDIVAL, Santander, Spain

Quach, H:
 Univ Melbourne, St Vincents Hosp Melbourne, Melbourne, Australia

Ramasamy, K:
 Univ Oxford, Oxford Translat Myeloma Ctr, NDORMS, Oxford, England

 Churchill Hosp, Oxford, England

:
 Hosp Univ Germans Trias Pujol, Inst Catala Oncol, Badalona, Spain

 Hosp Univ Germans Trias Pujol, Inst Josep Carreras, Badalona, Spain

Rodriguez-Otero, P:
 Clin Univ Navarra, Canc Ctr, Pamplona, Spain

Sanchez, RG:
 Univ Hosp Virgen de la Victoria, Dept Hematol, Malaga, Spain

Sandhu, I:
 Univ Alberta, Edmonton, AB, Canada

Weisel, K:
 Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

Brawley, C:
 GSK, Dev Biostat Oncol, London, England

Murillo, M:
 GSK, Oncol Clin Dev, Stevenage, England

Carreño, F:
 GSK, Clin Pharmacol Modeling & Simulat, Upper Providence, PA USA

Egger, J:
 GSK, Oncol Clin Dev, London, England

Kaisermann, M:
 GSK, Oncol Clin Dev, Upper Providence, PA USA

Hus, M:
 Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas:
WOS Id: 001664500400040

MÉTRICAS